HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy of gamithromycin for the treatment of foals with mild to moderate bronchopneumonia.

AbstractBACKGROUND:
Gamithromycin is active in vitro against the bacterial agents most commonly associated with bronchopneumonia in older foals. However, the clinical efficacy and safety of this drug have not been investigated.
HYPOTHESIS:
Gamithromycin is effective for the treatment of bronchopneumonia in foals.
ANIMALS:
One hundred and twenty-one foals on a farm endemic for infections caused by Rhodococcus equi.
METHODS:
In a controlled, randomized, and double blinded clinical trial, foals with ultrasonographic evidence of pulmonary abscesses (abscess score 8.0-20 cm) were randomly allocated in 3 treatment groups: (1) gamithromycin IM q7 days (n = 40); (2) azithromycin with rifampin, PO q24h (n = 40); or (3) no antimicrobial treatment (controls; n = 41). Physical examination and thoracic ultrasonography were performed by individuals unaware of treatment group assignment. Foals that worsened were removed from the study.
RESULTS:
The proportion of foals that recovered without the need to be removed from the study was significantly higher for foals treated with gamithromycin (38 of 40) or azithromycin with rifampin (39 of 40) than for controls (32 of 41). Treatment with gamithromycin or with azithromycin-rifampin resulted in a significantly faster decrease in the clinical score and abscess score compared to the controls. Adverse reactions characterized by colic (n = 18) and hind limb lameness (n = 14) were observed only in foals treated with gamithromycin.
CONCLUSION AND CLINICAL IMPORTANCE:
Gamithromycin was noninferior to azithromycin with rifampin for the treatment of bronchopneumonia in the study population but had a higher frequency of adverse reactions.
AuthorsF Hildebrand, M Venner, S Giguère
JournalJournal of veterinary internal medicine (J Vet Intern Med) Vol. 29 Issue 1 Pg. 333-8 (Jan 2015) ISSN: 1939-1676 [Electronic] United States
PMID25619521 (Publication Type: Journal Article, Randomized Controlled Trial)
CopyrightCopyright © 2015 by the American College of Veterinary Internal Medicine.
Chemical References
  • Anti-Bacterial Agents
  • Macrolides
  • Azithromycin
  • Rifampin
  • gamithromycin
Topics
  • Abscess (microbiology, veterinary)
  • Actinomycetales Infections (veterinary)
  • Animals
  • Anti-Bacterial Agents (therapeutic use)
  • Azithromycin (administration & dosage, therapeutic use)
  • Bronchopneumonia (drug therapy, veterinary)
  • Double-Blind Method
  • Drug Therapy, Combination
  • Female
  • Horse Diseases (drug therapy, microbiology)
  • Horses
  • Macrolides (therapeutic use)
  • Male
  • Rhodococcus equi
  • Rifampin (administration & dosage, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: